Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cell clonality assays: how do they compare?

Antonio Cozzio1, Lars E French

  • 1Department of Dermatology, Zurich University Hospital, Zurich, Swizerland.

The Journal of Investigative Dermatology
|March 14, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis.

International journal of dermatology·2026
Same author

Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.

The Journal of allergy and clinical immunology·2026
Same author

Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

The Lancet. Haematology·2026
Same author

[Diagnosis and management of chronic hand eczema in practice].

Praxis·2025
Same author

Updated Swiss Practice Recommendations for the Treatment of Acne.

Praxis·2025
Same author

Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany.

Mycoses·2025
Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026
Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
See all related articles

Distinguishing benign skin conditions from cutaneous T-cell lymphoma (CTCL) is difficult. Analyzing T-cell receptor (TCR) gene rearrangements helps identify monoclonality, aiding diagnosis.

Area of Science:

  • Dermatology
  • Oncology
  • Immunology

Background:

  • Differentiating benign lymphocytic infiltrates from cutaneous T-cell lymphoma (CTCL) poses clinical challenges.
  • T-cell receptor (TCR) gene rearrangement analysis is a valuable tool for assessing T-cell clonality.
  • Monoclonality indicates a tumor's origin from a single cell, crucial for early tumorigenesis understanding.

Discussion:

  • Monoclonal populations can evolve genetic heterogeneity and subclones during tumor progression.
  • This heterogeneity complicates the interpretation of clonality in advanced stages.
  • Understanding these dynamics is key for accurate diagnosis and treatment.

Key Insights:

  • T-cell clonality assessment via TCR gene rearrangements aids in diagnosing challenging cutaneous infiltrates.

Related Experiment Videos

  • Early-stage tumors are often monoclonal, originating from a single cell.
  • Tumor evolution can lead to genetic instability and subclone development.

    • Outlook:

    • Further refinement of TCR analysis may improve diagnostic accuracy for CTCL.
    • Investigating mechanisms of genetic heterogeneity in CTCL is essential.
    • Developing strategies to manage or target tumor subclones is a future direction.